MétaCan
Menu
Back to cohort
Record W4308769143 · doi:10.1183/13993003.01514-2022

Prolonged higher dose methylprednisolone<i>versus</i>conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS)

2022· article· en· W4308769143 on OpenAlexaff
Francesco Salton, Paola Confalonieri, Stefano Centanni, Michele Mondoni, Nicola Petrosillo, Paolo Bonfanti, Giuseppe Lapadula, Donato Lacedonia, Antonio Voza, Nicoletta Carpenè, Marcella Montico, Nicolò Reccardini, G. Umberto Meduri, Barbara Ruaro, Marco Confalonieri, Gloria Maria Citton, Giulia Lapadula, Chiara Bozzi, Stefano Tavano, Riccardo Pozzan, Alessia Giovanna Andrisano, Mohamad Y. Jaber, Marco Mari, Liliana Trotta, Lucrezia Mondini, Mariangela Barbieri, Luca Ruggero, Caterina Antonaglia, Sara Soave, Chiara Torregiani, Tjaša Bogatec, Andrea Baccelli, Giulia Nalesso, Beatrice Re, Stefano Pavesi, Maria Pia Foschino Barbaro, Antonella Giuliani, Claudia Ravaglia, Venerino Poletti, Raffaele Scala, Luca Guidelli, Nicoletta Golfi, Andrea Vianello, A. Achille, Paolo Lucernoni, Anna Talia Gaccione, Micaela Romagnoli, Alessia Fraccaro, Nicola Malacchini, Mario Malerba, Beatrice Ragnoli, Alessandro Sanduzzi, Marialuisa Bocchino, Francesco Blasi, Maura Spotti, Carmen Miele, Federica Piedepalumbo, Ivan Barone, Stefano Baglioni, Meridiana Dodaj, Cosimo Franco, Francesco Andrani, A. Mangia, Annalisa Mancini, Laura Carrozzi, A Rafanelli, Elisabetta Casto, Paola Rogliani, Josuel Ora, Giovanna Elisiana Carpagnano, Valentina Di Lecce, Mario Tamburrini, Alberto Papi, Marco Contoli, Roberto Luzzati, Marta Zatta, Stefano Di Bella, Emanuela Caraffa, Daniela Francisci, Andrea Tosti, Carlo Pallotto, Francesco Giuseppe De Rosa, Alessio Pecori, Marta Franceschini, Massimiliano Carlin, Valentina Orsini, Anna Spolti, Marta Inannace, Teresa Santantonio, Rossella Meli, Sara Sauro, Carlo Fedeli, Elisabetta Mangini, Gianni Biolo, Alessio Nunnari, Antonello Pietrangelo, Elena Corradini, Davide Bocchi, Chiara Boarini, Antonella Zucchetto, Simone Lanini

Bibliographic record

VenueEuropean Respiratory Journal · 2022
Typearticle
Languageen
FieldMedicine
TopicCOVID-19 Clinical Research Studies
Canadian institutionsUniversity Hospital Foundation
Fundersnot available
KeywordsMedicineMethylprednisoloneInterquartile rangeDexamethasoneFraction of inspired oxygenRandomized controlled trialMechanical ventilationPneumoniaIntensive care unitAnesthesiaInternal medicine

Abstract

fetched live from OpenAlex

Background Dysregulated systemic inflammation is the primary driver of mortality in severe coronavirus disease 2019 (COVID-19) pneumonia. Current guidelines favour a 7–10-day course of any glucocorticoid equivalent to dexamethasone 6 mg daily. A comparative randomised controlled trial (RCT) with a higher dose and a longer duration of intervention was lacking. Methods We conducted a multicentre, open-label RCT to investigate methylprednisolone 80 mg as a continuous daily infusion for 8 days followed by slow taperingversusdexamethasone 6 mg once daily for up to 10 days in adult patients with COVID-19 pneumonia requiring oxygen or noninvasive respiratory support. The primary outcome was reduction in 28-day mortality. Secondary outcomes were mechanical ventilation-free days at 28 days, need for intensive care unit (ICU) referral, length of hospitalisation, need for tracheostomy, and changes in C-reactive protein (CRP) levels, arterial oxygen tension/inspiratory oxygen fraction (PaO2/FIO2) ratio and World Health Organization Clinical Progression Scale at days 3, 7 and 14. Results 677 randomised patients were included. Findings are reported as methylprednisolone (n=337)versusdexamethasone (n=340). By day 28, there were no significant differences in mortality (35 (10.4%)versus41 (12.1%); p=0.49) nor in median mechanical ventilation-free days (median (interquartile range (IQR)) 23 (14)versus24 (16) days; p=0.49). ICU referral was necessary in 41 (12.2%)versus45 (13.2%) (p=0.68) and tracheostomy in 8 (2.4%)versus9 (2.6%) (p=0.82). Survivors in the methylprednisolone group required a longer median (IQR) hospitalisation (15 (11)versus14 (11) days; p=0.005) and experienced an improvement in CRP levels, but not inPaO2/FIO2ratio, at days 7 and 14. There were no differences in disease progression at the prespecified time-points. Conclusion Prolonged, higher dose methylprednisolone did not reduce mortality at 28 days compared with conventional dexamethasone in COVID-19 pneumonia.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.007
Threshold uncertainty score0.024

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.004
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0050.004
Bibliometrics0.0010.001
Science and technology studies0.0010.002
Scholarly communication0.0020.001
Open science0.0010.001
Research integrity0.0030.003
Insufficient payload (model declined to judge)0.0070.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.107
GPT teacher head0.415
Teacher spread0.308 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations49
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueEuropean Respiratory JournalSame topicCOVID-19 Clinical Research StudiesFrench-language works237,207